In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Orion divests Orion Diagnostica division to PE firm Axcel for up to €223mm

Executive Summary

An investment fund managed by Nordic private equity investment company Axcel Management AS agreed to acquire Orion Diagnostica Oy (point-of-care testing instruments and kits) for a fixed price of €163mm ($201.5mm), three times the company's 2017 net sales of €54.8mm.
Deal Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Full Acquisition
    • Buy-out
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register